Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85483ac98517c2c3d67bb829aa5d816f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06 |
filingDate |
2010-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4cd9b9114a90491800a9861303a3973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da9f66fd20a2a975bdf8e0eda1543f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994b96f444004bfa2f383dffc77298d2 |
publicationDate |
2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112012014190-B1 |
titleOfInvention |
pharmaceutical composition for the treatment of dry eye syndrome |
abstract |
pharmaceutical composition for the treatment of dry eye syndrome. the invention dries new pharmaceutical compositions for the treatment of dry keratoconjunctivitis comprising liquid carriers that include one or more semifluorinated alkanes. the compositions incorporate an active ingredient selected from the group of macrolide immunosuppressants. can be administered topically to the eye. the invention further provides kits that comprise such compositions. |
priorityDate |
2009-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |